The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults
A Randomised-controlled Trial on the Effectiveness of Topical Sesame Oil in Preventing Phlebitis at Intravenous Cannula Sites in Adult Patients
1 other identifier
interventional
263
1 country
1
Brief Summary
The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital. The main question it aims to answer is: Is topical sesame oil effective in preventing phlebitis at peripheral IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital? Participants will be randomly allocated to the experimental or control group with the use of a randomisation software (MS excel). They will each have five drops/0.25mls of 100% sesame oil (experimental) or liquid paraffin oil (control) applied to the IV cannula site, at 12 hourly intervals for a total of 72 hours, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side. Researchers will compare the phlebitis incidence and severity of each group to see if topical sesame oil is more effective than liquid paraffin oil in preventing phlebitis at IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2022
CompletedFirst Submitted
Initial submission to the registry
January 11, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedFebruary 21, 2024
February 1, 2024
6 months
January 11, 2024
February 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phlebitis incidence
Measuring the incidence of phlebitis across both the intervention and control groups
At 12 hourly intervals for a total of 72 hours
Secondary Outcomes (1)
Phlebitis severity
At 12 hourly intervals for a total of 72 hours
Study Arms (2)
Intervention
EXPERIMENTAL5 drops/0.25mls of 100% sesame oil will be applied to the IV cannula site, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side, every 12 hours for 72 hours.
Control
PLACEBO COMPARATOR5 drops/0.25mls of liquid paraffin oil will be applied to the IV cannula site, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side, every 12 hours for 72 hours.
Interventions
5 drops/0.25mls of sesame oil applied to the IV cannula site at 12 hourly intervals for 72 hours
5 drops/0.25mls of liquid paraffin oil applied to the IV cannula site at 12 hourly intervals for 72 hours
Eligibility Criteria
You may qualify if:
- Age 21-80
- Patients must speak and understand either English or Mandarin
- Patients who possess a peripheral IV cannula
- IV cannula must have been inserted for less than 12 hours
- IV cannula must be on an upper extremity
- IV cannula must be patent
- IV cannula sites must show no signs of redness, swelling, pain, a palpable venous cord or pyrexia
- Patient must be admitted to a cardiology ward in the National Heart Centre Singapore
You may not qualify if:
- Patients who do not speak or understand either English or Mandarin
- Patients with venous insufficiency
- Patients with coagulopathies
- Patients with cognitive or sensory impairments that would inhibit their ability to rate their pain via a Numerical Rating Scale (NRS)
- Patients who are receiving medications that might interfere with timely reporting of adverse events (eg. medications that cause severe drowsiness)
- Patients who report allergies to sesame or liquid paraffin oil
- IV cannulas that were inserted and used for resuscitation
- Patients with existing skin conditions that cause their skin to be red or swollen and might affect the investigators ability to assess for phlebitis
- Patients who possess more than one peripheral IV cannula will only be included in the study once. All subsequent IV cannula insertions will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Heart Centre Singapore
Singapore, 169609, Singapore
Related Publications (1)
Jackson A. Infection control--a battle in vein: infusion phlebitis. Nurs Times. 1998 Jan 28-Feb 3;94(4):68, 71. No abstract available.
PMID: 9510815BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jasmine Tan
Nanyang Polytechnic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2024
First Posted
January 22, 2024
Study Start
April 12, 2022
Primary Completion
October 21, 2022
Study Completion
October 21, 2022
Last Updated
February 21, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share